About usAdcock Ingram at a Glance
Our Strategy
Adcock Ingram has three strategic focus areas which are driven from a Group level.
The strategies will deliver
businesses that return long-term profit growth and create sustainable value for all stakeholders.
- Customers
- Products
- Service
- Build on the FoundationTo protect our margins
- Growth and ExpansionTo expand product portfolios and to secure growth
and sustainability - TransformationTo focus on broad-based empowerment initiatives
to maximise the Group's B-BBEE credentials
Leadership review from our Chairman and CEO
Chief Executive Officer LINDSAY RALPHS
Chairman
"Adcock Ingram is regarded as an essential service provider, and therefore no restrictions were imposed on the operations during the lockdown, albeit that the effects of the pandemic were evident across the business units in varying degrees."
Operational review
- CONSUMER
- OVER THE COUNTER
- Prescription
- HOSPITAL
A closer look at our operating model
Our business activities
The division is focused on the marketing, selling and distribution of Healthcare, Personal Care, and Homecare brands.
Managing Director Lauren Shimmin
Financial Director
A closer look at our operating model
Our business activities
The Over the Counter (AI OTC) division manufactures and supplies medication for patients and consumers predominantly in the self-medication category, mainly at Pharmacy level but also to a lesser extent in the FMCG channel. Its commercial focus in South Africa includes the private and public sectors with geographic reach expanding into a number of export markets.
Financial Director Yudhveer Singh
Managing Director
A closer look at our operating model
OUR BUSINESS ACTIVITIES
The division focuses on building and offering a broad range of medicines in targeted therapeutic areas for patients consulting healthcare professionals, where prescriptions are generally required. The business has a comprehensive portfolio of quality and aff ordable branded and generic medicines and also markets a range of innovator brands on behalf of multinational partners, including Leo Pharma, Novo Nordisk, Sandoz, Lundbeck, Takeda and Roche.
Financial Director Ashley Pearce
Managing Director
A closer look at our operating model
OUR BUSINESS ACTIVITIES
Adcock Ingram Critical Care (AICC) is a leading manufacturer and supplier of hospital and critical care products in Southern Africa. Products are off ered through multiple portfolios and across wide-ranging customer channels. The business is a fully integrated operation which spans through regulatory, R&D, manufacturing, marketing, sales and distribution. Beyond its world-class commercial capability, AICC manufactures an extensive range of products in its unique dual process factory which comprises a comprehensive plastics extrusion plant together with a fully accredited pharmaceuticals manufacturing facility.
Financial Director Colin Sheen
Managing Director